Anne Boulay
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 5%
- Neurology top 2%
- Co-authors
- Heidi A. LaneTerence O’ReillyMartine Cohen‐SalmonGeorge ThomasSabine Zumstein-MeckerNancy E. HynesFrédéric ZilbermannIwan Beuvink
- Topics
- Barrier Structure and Function Studies (13 papers)PI3K/AKT/mTOR signaling in cancer (8 papers)Connexins and lens biology (8 papers)
- Cited by
- NeurologyCancer ResearchOncology
- Partner nations
- FranceSwitzerlandUnited Kingdom
In The Last Decade
Anne Boulay
55 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 2.0k
- Oncology 863
- Cancer Research 574
- Pulmonary and Respiratory Medicine 531
- Neurology 401
Countries citing papers authored by Anne Boulay
This map shows the geographic impact of Anne Boulay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Boulay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Boulay more than expected).
Fields of papers citing papers by Anne Boulay
This network shows the impact of papers produced by Anne Boulay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Boulay. The network helps show where Anne Boulay may publish in the future.
Co-authorship network of co-authors of Anne Boulay
This figure shows the co-authorship network connecting the top 25 collaborators of Anne Boulay. A scholar is included among the top collaborators of Anne Boulay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Boulay. Anne Boulay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 7 | |
| 5 | 34 | |
| 6 | 15 | |
| 7 | 49 | |
| 8 | 10 | |
| 9 | The novel bispecific monoclonal anti-VEGF/anti-Ang2 antibody RG7716 shows promise in wet age-related macular degeneration patients with suboptimal response to prior anti-VEGF monotherapy | 1 |
| 10 | 56 | |
| 11 | 67 | |
| 12 | 177 | |
| 13 | 15 | |
| 14 | 196 | |
| 15 | 92 | |
| 16 | 28 | |
| 17 | 35 | |
| 18 | Differential anti-vascular effects of mTOR or VEGFR pathway inhibition: A rational basis for combining RAD001 and PTK787/ZK222584 | 9 |
| 19 | 426 | |
| 20 | The mTOR pathway in estrogen response: A potential for combining the rapamycin derivative RAD001 with the aromatase inhibitor Letrozole (Femara®) in breast carcinoma | 23 |
About Anne Boulay
Anne Boulay is a scholar working on Neurology, Cancer Research and Cell Biology, having authored 57 papers that have together received 3.3k indexed citations. Recurring topics across this work include Barrier Structure and Function Studies (13 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Connexins and lens biology (8 papers). The work is most often cited by research in Neurology (401 citations), Cancer Research (574 citations) and Oncology (863 citations). Anne Boulay has collaborated with scholars based in France, Switzerland and United Kingdom. Frequent co-authors include Heidi A. Lane, Terence O’Reilly, Martine Cohen‐Salmon, George Thomas, Sabine Zumstein-Mecker, Nancy E. Hynes, Frédéric Zilbermann, Iwan Beuvink, Bruno Saubaméa and Stephan Ruetz. Their work appears in journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.